ライフサイエンスコーパス: human chorionic gonadotropin

1 ceptor for luteinizing or pregnancy hormone (human chorionic gonadotropin).

2 h weekly levels of estrone-3-glucuronide and human chorionic gonadotropin.

3 es on the day of induction of ovulation with human chorionic gonadotropin.

4 induced ovulation with a single injection of human chorionic gonadotropin.

5 ectrical resistance (TEER) and the amount of human chorionic gonadotropin.

6 or estrogen and progesterone metabolites and human chorionic gonadotropin.

7 diated by high circulating concentrations of human chorionic gonadotropin.

8 ty associated with the beta-core fraction of human chorionic gonadotropin.

9 miR levels were compared with those of beta-human chorionic gonadotropin, alpha-fetoprotein, and lac

10 ity to block release of the secreted protein human chorionic gonadotropin-alpha.

11 pregnant mare serum gonadotropin followed by human chorionic gonadotropin also stimulated cumulus exp

12 administration of exogenous testosterone or human chorionic gonadotropin (an LH receptor agonist), r

13 ased on an increased blood level of the beta human chorionic gonadotropin and a histopathological exa

14 mg per day on days 1, 8, and 15]), patients' human chorionic gonadotropin and alfa-fetoprotein concen

15 Patients with a favourable decline in human chorionic gonadotropin and alfa-fetoprotein contin

16 ists) and exogenous gonadotropins (including human chorionic gonadotropin and follicle-stimulating ho

17 ght to be induced by two placental hormones: human chorionic gonadotropin and human chorionic somatot

18 were significantly, directly associated with human chorionic gonadotropin and inversely with estrone-

19 , and elevated preorchiectomy levels of beta-human chorionic gonadotropin and lactate dehydrogenase w

20 Increased leptin levels, as well as human chorionic gonadotropin and luteinizing hormone rec

21 f maternal age, maternal levels of free beta human chorionic gonadotropin and pregnancy-associated pl

22 nt of two maternal serum hormones, free beta-human chorionic gonadotropin and pregnancy-associated pl

23 n maternal age, maternal levels of free beta human chorionic gonadotropin and pregnancy-associated pl

24 gically, biochemically (by the production of human chorionic gonadotropin and progesterone), and immu

25 Pretreatment serum concentrations of human chorionic gonadotropin and progesterone, the size

26 rculating levels of the free beta subunit of human chorionic gonadotropin and stillbirth risk.

27 ment of tumor markers (alpha fetoprotein and human chorionic gonadotropin), and imaging.

28 Thyroid function, human chorionic gonadotropin, and estradiol were measure

29 alpha-Fetoprotein, beta-human chorionic gonadotropin, and lactate dehydrogenase

30 serum tumor markers (alpha-fetoprotein, beta-human chorionic gonadotropin, and lactate dehydrogenase)

31 serum tumor markers [alpha-fetoprotein, beta-human chorionic gonadotropin, and lactate dehydrogenase]

32 edent pregnancy, serum concentration of beta-human chorionic gonadotropin, and stage of disease, with

33 cosylated protein domains (F(c)) of two anti-human chorionic gonadotropin antibodies were proteolytic

34 antibody-antigen immune reaction by binding human chorionic gonadotropin antigen to immunoglobulin a

35 els of alpha-fetoprotein and beta-subunit of human chorionic gonadotropin are used as biomarkers for

36 elopment of effective treatments, the use of human chorionic gonadotropin as a biomarker, and central

37 ot confirm the primary site and the level of human chorionic gonadotropin as independent factors.

38 ein A [PAPP-A], and the free beta subunit of human chorionic gonadotropin at 10 weeks 3 days through

39 iers) that predicts pregnancy using the beta human chorionic gonadotropin (b-hCG) test from both the

40 The rate of HBsAg in 6,976 B-human chorionic gonadotropin (B-hCG)-positive specimens,

41 recognizes the GVL peptide (GVLPALPQV) from human chorionic gonadotropin beta presented by the pepti

42 Disrupting disulfide loops in the human chorionic gonadotropin beta subunit (CGbeta) inhib

43 e Fas, urothelial carcinoma-associated 1 and human chorionic gonadotropin beta type II genes.

44 intracellular kinetic folding pathway of the human chorionic gonadotropin beta-subunit (hCG-beta) rev

45 g ability to secretion and assembly with the human chorionic gonadotropin beta-subunit (hCG-beta).

46 n choriocarcinoma that was confirmed by beta human chorionic gonadotropin (beta-HCG) levels and histo

47 e assessed for four mRNA tumor markers: beta-human chorionic gonadotropin (beta-hCG), oncogene recept

48 ative serum alpha-fetoprotein (AFP) and beta-human chorionic gonadotropin (betaHCG) levels were 483 n

49 ligand signaling despite moderate levels of human chorionic gonadotropin binding in transfected cell

50 vivo, treatment with a desensitizing dose of human chorionic gonadotropin caused transcriptional down

51 odimers, which include the placental hormone human chorionic gonadotropin (CG) and the anterior pitui

52 Human chorionic gonadotropin (CG) is a member of a famil

53 chimeric glycoprotein substrates by agalacto human chorionic gonadotropin, comprising 29 nM for beta4

54 (3.7 [1.9-7.4], p=0.0002), and pretreatment human chorionic gonadotropin concentration (2.8 [1.9-4.1

55 etastases or choriocarcinoma, a pretreatment human chorionic gonadotropin concentration of 149 000 IU

56 and without choriocarcinoma, a pretreatment human chorionic gonadotropin concentration of 411 000 IU

57 choriocarcinoma, regardless of pretreatment human chorionic gonadotropin concentration, or to those

58 delling to define thresholds of pretreatment human chorionic gonadotropin concentrations and identify

59 of mutant receptors and is dependent on the human chorionic gonadotropin dose, the surface concentra

60 leptin, cortisol, and reproductive hormones (human chorionic gonadotropin, estradiol, progesterone, h

61 rning urine samples were collected to assess human chorionic gonadotropin, estrone-3-glucuronide, and

62 ciated pre-mRNA encoding the beta-subunit of human chorionic gonadotropin gene 6 and pre-trans-splici

63 lines of prior therapy (P < .001), baseline human chorionic gonadotropin > or = 1,000 U/L (P = .01),

64 sk disease at the time of GCT diagnosis, and human chorionic gonadotropin >/= 1,000 mIU/mL at initiat

65 ultrasonography and sensitive tests for beta-human chorionic gonadotropin have evolved, the presentat

66 kers were alpha-fetoprotein (AFP) 2.0 ng/mL, human chorionic gonadotropin (hCG) 151,111 IU/L, and lac

67 multiple preovulatory follicles, followed by human chorionic gonadotropin (hCG) administration (day 0

68 sa cell NTS mRNA and protein increased after human chorionic gonadotropin (hCG) administration, which

69 Previous studies on human chorionic gonadotropin (hCG) and human follicle-st

70 cribe chimeras of two glycoprotein hormones, human chorionic gonadotropin (hCG) and human follitropin

71 G-protein coupled receptor activated by both human chorionic gonadotropin (hCG) and luteinizing hormo

72 nesis by adrenocorticotropic hormone (ACTH), human chorionic gonadotropin (hCG) and oestrogen, and in

73 In contrast, human chorionic gonadotropin (hCG) and other glycoprotei

74 e immunoassays for two model cancer markers, human chorionic gonadotropin (hCG) and prostate specific

75 Bovine lutropin (bLH) and human chorionic gonadotropin (hCG) are heterodimeric gly

76 Human luteinizing hormone (hLH) and human chorionic gonadotropin (hCG) are human glycoprotei

77 Using human chorionic gonadotropin (hCG) as a model analyte to

78 nsitivity, which has been demonstrated using human chorionic gonadotropin (hCG) as an example.

79 s of NPFF-NPFFR2 on expression of syncytial [human chorionic gonadotropin (hCG) beta] and fusogenic [

80 Human chorionic gonadotropin (hCG) binds to the exodomai

81 Human chorionic gonadotropin (hCG) binds to the extracel

82 Serum human chorionic gonadotropin (hCG) concentration was 200

83 ational trophoblastic disease include raised human chorionic gonadotropin (hCG) concentrations 6 mont

84 ntly, we proposed that the pregnancy hormone human chorionic gonadotropin (hCG) efficiently attracts

85 have questioned whether women with PMs need human chorionic gonadotropin (hCG) follow-up.

86 examined by univariate analysis; only serum human chorionic gonadotropin (HCG) had an impact on surv

87 Human chorionic gonadotropin (hCG) has been shown to red

88 Recently, certain preparations of human chorionic gonadotropin (hCG) have been shown to in

89 onadotropin-releasing hormone (GnRH) gene by human chorionic gonadotropin (hCG) in GT1-7 neurons.

90 Treatment with human chorionic gonadotropin (HCG) increased levels of p

91 Human chorionic gonadotropin (hCG) induces de novo synth

92 omas in immune-compromised mice that secrete human chorionic gonadotropin (hCG) into the host mouse a

93 Human chorionic gonadotropin (hCG) is a glycoprotein hor

94 Human chorionic gonadotropin (hCG) is a glycoprotein sec

95 Human chorionic gonadotropin (hCG) is a heterodimeric gl

96 Human chorionic gonadotropin (hCG) is a heterodimeric me

97 Human chorionic gonadotropin (hCG) is an important bioma

98 obably down-regulated at about the time that human chorionic gonadotropin (hCG) is first expressed in

99 Human chorionic gonadotropin (hCG) is necessary for the

100 Human chorionic gonadotropin (hCG) is one of the earlies

101 ting studies do not establish a single serum human chorionic gonadotropin (hCG) level that is diagnos

102 Pregnancy detected using human chorionic gonadotropin (hCG) levels.

103 b 10 mg/kg intravenously every 2 weeks until human chorionic gonadotropin (hCG) normalization, follow

104 ects of clinical grade crude preparations of human chorionic gonadotropin (hCG) on Kaposi's sarcoma,

105 The impact of human chorionic gonadotropin (hCG) on prostate carcinoma

106 Human chorionic gonadotropin (hCG) preparations contain

107 Recent clinical trials with human chorionic gonadotropin (hCG) prepared from early p

108 Human chorionic gonadotropin (hCG) promotes proliferatio

109 gh sensitivity, affinity and specificity for human chorionic gonadotropin (hCG) protein.

110 The human chorionic gonadotropin (hCG) proteins constitute a

111 Treatment of mice with human chorionic gonadotropin (hCG) resulted in increased

112 The hormone human chorionic gonadotropin (hCG) serves to maintain th

113 Human chorionic gonadotropin (hCG) suppresses cell-media

114 cinoma on the basis of persistently positive human chorionic gonadotropin (hCG) test results in the a

115 We detect human chorionic gonadotropin (hCG) using an antibody-bas

116 GRTH gene transcription is stimulated by human chorionic gonadotropin (hCG) via cyclic AMP-induce

117 t drug resistance to EMA/CO, and because the human chorionic gonadotropin (hCG) was near normal, they

118 In the present work human chorionic gonadotropin (hCG) was used as a model p

119 tural cycles, no oestrogen, progesterone, or human chorionic gonadotropin (hCG) was used.

120 s on a rat breast cancer model indicate that human chorionic gonadotropin (hCG), a hormone that is pr

121 Experimental observations suggest that human chorionic gonadotropin (hCG), a major hormone of p

122 Results of recent studies suggest that human chorionic gonadotropin (HCG), a placental glycopro

123 hich recognizes both luteinizing hormone and human chorionic gonadotropin (hCG), as the tissue-specif

124 markers, human C-reactive protein (CRP) and human chorionic gonadotropin (hCG), by using fluorescent

125 various pregnancy-related hormones including human chorionic gonadotropin (hCG), estrogen, progestero

126 in utilized as a model system in this study, human chorionic gonadotropin (hCG), exists as a heterodi

127 ococci express a surface feature that mimics human chorionic gonadotropin (hCG), the cognate ligand f

128 rum alpha-fetoprotein, unconjugated estriol, human chorionic gonadotropin (hCG), the free beta subuni

129 Furthermore, using the mediator molecule human chorionic gonadotropin (hCG), we interface the int

130 ecognizes the peptide GVLPALPQV derived from human chorionic gonadotropin (hCG)-beta.

131 gnal of the conceptus during implantation is human chorionic gonadotropin (hCG).

132 , for the common performance enhancing drug, human chorionic gonadotropin (hCG).

133 retion of placental growth factor (PlGF) and human chorionic gonadotropin (hCG).

134 s were verified for the efficient binding of Human Chorionic Gonadotropin (hCG).

135 oblastoma cells before and after exposure to human chorionic gonadotropin (hCG).

136 imit of normal, 8.0 ug/L), and a normal beta-human chorionic gonadotropin (HCG).

137 ionally constrained than the beta-subunit of human chorionic gonadotropin (hCG-beta).

138 es of lactate dehydrogenase (LDH; .0001) and human chorionic gonadotropin (HCG; .0001).

139 ring three markers (alpha-fetoprotein [AFP], human chorionic gonadotropin [hCG], and lactate dehydrog

140 EREG, and the intracellular beta subunit of human chorionic gonadotropin (hCGbeta) and peroxisome pr

141 scent detection of three markers: beta-chain human chorionic gonadotropin, hepatocyte growth factor r

142 samples and real immunorecognition assays of human chorionic gonadotropin hormone are well below the

143 ection of a set of three fertility hormones: human chorionic gonadotropin, human luteinizing hormone,

144 irole and stimulation of cAMP synthesis with human chorionic gonadotropin in cells transfected with e

145 n alone in three, alpha-fetoprotein and beta human chorionic gonadotropin in one) suffered a relapse,

146 h the chimeric receptor could not respond to human chorionic gonadotropin in producing cAMP, co-expre

147 Human chorionic gonadotropin increased GRTH gene express

148 an be pharmacologically rescued by exogenous human chorionic gonadotropin, indicating that LH-respons

149 The administration of human chorionic gonadotropin induced a dramatic increase

150 dicated that age, preceding pregnancy event, human chorionic gonadotropin level, World Health Organiz

151 42 mmol/L]), and serum alpha-fetoprotein and human chorionic gonadotropin levels were normal.

152 Serum and CSF alpha-fetoprotein and beta-human chorionic gonadotropin levels were not associated

153 Activation of the luteinizing hormone/human chorionic gonadotropin (LH/hCG) receptor (LHR) in

154 Point mutations in the luteinizing hormone/human chorionic gonadotropin (LH/hCG) receptor have been

155 d with the regulation of luteinizing hormone/human chorionic gonadotropin (LH/hCG) receptor mRNA stab

156 Multiple luteinizing hormone/human chorionic gonadotropin (LH/hCG) receptor mRNAs (6.

157 The luteinizing hormone/human chorionic gonadotropin (LH/hCG) receptor, which be

158 ge, 5-12 mug/dL [64.35-154.44 nmol/L]), beta-human chorionic gonadotropin (<1.2 mIU/mL; normal, <5 mI

159 nge, 5-12 ug/dL [64.35-154.44 nmol/L]), beta-human chorionic gonadotropin (<1.2 mIU/mL; normal, <5 mI

160 For anti-hCG (human chorionic gonadotropin) mAb 8F11, studied at two i

161 ts had increased alpha fetoprotein (n = 18), human chorionic gonadotropin (n = 5), or both (n = 2); n

162 opin-releasing hormone analogs [n = 38 653], human chorionic gonadotropin [n = 68 181], progesterone

163 engineered hCG-SNAP fusion reporter protein (human chorionic gonadotropin-O(6) -alkylguanine-DNA alky

164 ha-fetoprotein of 100 ng/mL or greater or of human chorionic gonadotropin of 5,000 U/L or greater (gr

165 clinical evidence and highly elevated serum human chorionic gonadotropin or alfa-fetoprotein concent

166 4 of them either after the administration of human chorionic gonadotropin or during the physiologic r

167 that its expression is increased 2.5-fold by human chorionic gonadotropin over a 12-h period.

168 were used to bind the glycoprotein hormone, human chorionic gonadotropin, produced during normal pre

169 and, over time, produce extensive amounts of human chorionic gonadotropin, progesterone, placental gr

170 mmune cells, such as progesterone, estrogen, human chorionic gonadotropin, prolactin, and relaxin.

171 Treatment of Leydig cells with human chorionic gonadotropin rapidly induced free radica

172 alpha-helix (TM3) of the luteinizing hormone/human chorionic gonadotropin receptor (LH/hCGR) in regul

173 The luteinizing hormone/human chorionic gonadotropin receptor (LH/hCGR) undergoe

174 metry assay) was inhibited by 57 %, and both human chorionic gonadotropin secretion and L-leucine inf

175 -derived CTBs in low oxygen leads to reduced human chorionic gonadotropin secretion and STB-associate

176 The human chorionic gonadotropin-stimulated phosphorylation

177 ed with WT mice by both in vivo and in vitro human chorionic gonadotropin stimulation.

178 failure was defined as a negative serum beta-human chorionic gonadotropin test (beta-hCG < 6 IU/L) 17

179 rual period, and a combination of a positive human chorionic gonadotropin test and an outpatient obst

180 The serum beta-human chorionic gonadotropin test result was negative fo

181 The serum beta-human chorionic gonadotropin test result was negative fo

182 logical pregnancy defined by a positive beta human chorionic gonadotropin test, two weeks after insem

183 ictive of a pregnancy outcome was a positive human chorionic gonadotropin test; least predictive was

184 pregnancy by interview and selective urinary human chorionic gonadotropin tests.

185 ased on a modified commercial strip test for human chorionic gonadotropin, the hormone used to detect

186 nsulin acts independently or additively with human chorionic gonadotropin to enhance androstenedione

187 ing (measurement of alpha-fetoprotein, total human chorionic gonadotropin, unconjugated estriol, and

188 and apply this platform to the detection of human chorionic gonadotropin using surface plasmon reson

189 rine specimens for up to 1 year, and urinary human chorionic gonadotropin was assayed to detect conce

190 Daily urinary human chorionic gonadotropin was assayed to detect conce

191 Using purified plasma membranes, human chorionic gonadotropin was similarly observed to h

192 Histologic subtype and increase of beta-human chorionic gonadotropin were not significantly corr

193 ved at low micromolar concentrations of hCG (human chorionic gonadotropin), while measured Kd values

194 with built-in signal amplification to detect human chorionic gonadotropin with an order of magnitude

195 been transvaginal sonography and serum beta-human chorionic gonadotropin, with diagnostic laparoscop